5377 Results

People

  1. O'Reilly
    O'Reilly
  2. Usmani
    Usmani
  3. Abu-Rustum
    Abu-Rustum
  4. Dee
    Dee
  5. Wei
    Wei
  6. Kingham
    Kingham
  7. Jarnagin
    Jarnagin
  8. Lee
    Lee
  9. Weigelt
    Weigelt
  10. Drilon
    Drilon

Groups

  1. Department of Medicine (2141)
  2. Solid Tumor Oncology Division (1382)
  3. Sloan Kettering Institute Postdocs (1038)
  4. Surgery (984)
  5. Graduate Medical Education (883)
  6. GSK Faculty (868)
  7. Survivorship Research (802)
  8. Population Sciences Research Program (722)
  9. Department of Pathology and Laboratory Medicine (719)
  10. Hematologic Malignancies, Division of (670)
  1. "2024"
Formats
  1. Journal Article (2329)
  2. Meeting Abstract (1694)
  3. Review (589)
  4. Editorial (305)
  5. Book Section (98)
  6. Correspondence (92)
  7. Guidelines (90)
  8. Research Letter (89)
  9. Miscellaneous (55)
  10. Conference Paper (33)
  11. Book Whole (3)
Groups
  1. Department of Medicine (2141)
  2. Solid Tumor Oncology Division (1382)
  3. Sloan Kettering Institute Postdocs (1038)
  4. Surgery (984)
  5. Graduate Medical Education (883)
  6. GSK Faculty (868)

More Groups

People
  1. Eileen O'Reilly (75)
  2. Saad Usmani (75)
  3. Edward Christopher Dee (70)
  4. Nadeem Abu-Rustum (70)
  5. Alice Wei (69)
  6. T Peter Kingham (68)

More People

Years
  1. 2024 (5377)
Publications
  1. Journal of Clinical Oncology (521)
  2. International Journal of Radiation Oncology, Biology, Physics (186)
  3. Blood (161)
  4. Annals of Oncology (147)
  5. Annals of Surgical Oncology (131)
  6. Laboratory Investigation (91)

More Publications

Publishers
  1. Elsevier Inc. (784)
  2. American Society of Clinical Oncology (580)
  3. Nature Publishing Group (384)
  4. Springer (357)
  5. Oxford University Press (347)
  6. Elsevier Science, Inc. (256)

More Publishers

Results (5377)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patients on the Internet: The information age and trust in medicine, conspiracies, and proliferation of false information
    Book Section

    Roth, A. J.; Lowy, J. A.; Matsoukas, K.
    In McFarland, D. C.; Grassi, L.; Silver, S. M.; Riba, M. B. (Eds.) The Complex Role of Patient Trust in Oncology (2024)

    Fulltext@MSK | Save
  • Neuroendocrine tumors: Beta labeled radiopeptides
    Review

    Bodei, L.; Jayaprakasam, V. S.; Ying Wong, B. Z.; Aparici, C. M.
    PET Clinics (2024)

    Fulltext@MSK | Save
  • Consultation-liaison psychiatry and psychological factors affecting other medical conditions
    Book Section

    Alici, Y.; Mc Farland, D. C.
    In Tasman, A.; Riba, M. B.; Alarcón, R. D.; Alfonso, C. A.; Kanba, S.; Lecic-Tosevski, D.; Ndetei, D. M.; Ng, C. H.; Schulze, T. G. (Eds.) Tasman’s Psychiatry. 5th ed (2024)

    Fulltext@MSK | Save
  • Lower extremity benign bone lesions and related conditions
    Book Section

    Karol, L.; Prince, D. E.
    In Sabharwal, S.; Iobst, C. A. (Eds.) Pediatric Lower Limb Deformities: Principles and Techniques of Management. 2nd ed (2024)

    Fulltext@MSK | Save
  • Technical innovations and new therapies to optimize functional outcomes after radiation therapy
    Book Section

    Kollmeier, M.; Silver, B.
    In Razdan, S.; Razdan, S. (Eds.) Urinary Continence and Sexual Function after Robotic Prostatectomy, Radiation, and Novel Therapies. 2nd ed (2024)

    Fulltext@MSK | Save
  • Getting PIKy with the lysosome membrane (again)
    Editorial

    Klein, A. D.; Overholtzer, M.
    Autophagy Reports (2024)

    Fulltext@MSK | Save
  • Role and relation of microbiome to address antimicrobial resistance
    Book Section

    Bhattacharya, C.; Dinc, M. T.; Basu, S.; Chaudhuri, R.; Fu, C.; Cervantes, G.; Adhikari, U. D.; Panja, R.; Qiu, J.; Aditya, A.; more...
    In Soni, V.; Suresh Akhade, A. (Eds.) Antimicrobial Resistance: Factors to Findings: Omics and Systems Biology Approaches (2024)

    Fulltext@MSK | Save
  • Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis
    Meeting Abstract

    Kieler, M.; Prammer, L.; Heller, G.; Hofmann, M.; Sperger, S.; Hanetseder, D.; Niederreiter, B.; Komljenovic, A.; Miller, A.; Klavins, K.; more...
    Annals of the Rheumatic Diseases (2024)

    Fulltext@MSK | Save
  • A randomized phase 2 trial of 28-day (Arm A) versus 14-day (Arm B) schedule of venetoclax + azacitidine in newly diagnosed acute myeloid leukemia patients ≥ 60 years
    Meeting Abstract

    Borate, U.; Huang, Y.; Zeidner, J. F.; Swords, R. T.; Koenig, K. L.; Stein, E. M.; Baer, M. R.; Stock, W.; Madanat, Y. F.; Olin, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Mosunetuzumab continues to demonstrate clinically meaningful outcomes in patients with relapsed and/or refractory follicular lymphoma after ≥ 2 prior therapies including those with a history of POD24: 4-year follow-up of a pivotal phase II study
    Meeting Abstract

    Shadman, M.; Bartlett, N. L.; Matasar, M.; Schuster, S. J.; Assouline, S. E.; Sehn, L. H.; Kuruvilla, J.; Giri, P.; Cheah, C. Y.; Dietrich, S.; more...
    Blood (2024)

    Fulltext@MSK | Save